The recommendations surround important updates to standard criteria that are commonly used despite being decades old.

Phase 3 ABTECT-Maintenance will report 44-week efficacy and safety of obefazimod in moderately to severely active UC using a randomized, double-blind, placebo-controlled design. Subset analyses will ...

Two structurally modified compounds derived from an anti-inflammatory metabolite demonstrated enhanced anti-inflammatory ...

Ulcerative colitis (UC) is a chronic inflammatory disease of the gastrointestinal tract, which is closely related to gut barrier dysfunction. Emerging evidence shows that interleukin-22 (IL-22) ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, which are adaptive immune cells, in triggering and sustaining colitis occurring ...

USA: In the phase IIb RELIEVE UCCD trial, investigational duvakitug improved clinical remission rates in patients with ulcerative colitis and endoscopic response rates in those with Crohn’s disease.

In a striking illustration of how far the reach of inflammatory bowel disease can extend beyond the gut, clinicians have ...

Connecticut's new menopause laws add workplace accommodation rights and order a doctor toolkit due by 2028. See what changes for workers and patients. A JAMA Network Open study found breastfeeding ...

Ischemic colitis reduces blood flow to the colon or large intestine. Mesenteric ischemia is a reduction in blood flow to the small intestine due to the narrowing of the arteries. Both conditions are ...

Four Canadian research teams will investigate new approaches to understanding, treating and preventing Crohn’s disease and ulcerative colitisTORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- As Canada’s ...

'Imagine having a wound that never heals. Only it’s on the inside and every time you eat or drink, it’s like rubbing salt into that wound.' When asked to explain the sensation of ulcerative colitis, ...